These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 19273790

  • 1. Early effects of intravitreal triamcinolone acetonide on inflammation and proliferation in human choroidal neovascularization.
    Tatar O, Adam A, Shinoda K, Kaiserling E, Boeyden V, Claes C, Eckardt C, Eckert T, Pertile G, Scharioth GB, Yoeruek E, Szurman P, Bartz-Schmidt KU, Grisanti S.
    Arch Ophthalmol; 2009 Mar; 127(3):275-81. PubMed ID: 19273790
    [Abstract] [Full Text] [Related]

  • 2. Influence of verteporfin photodynamic therapy on inflammation in human choroidal neovascular membranes secondary to age-related macular degeneration.
    Tatar O, Adam A, Shinoda K, Yoeruek E, Szurman P, Bopp S, Eckardt C, Bartz-Schmidt KU, Grisanti S.
    Retina; 2007 Mar; 27(6):713-23. PubMed ID: 17621180
    [Abstract] [Full Text] [Related]

  • 3. Early effects of triamcinolone on vascular endothelial growth factor and endostatin in human choroidal neovascularization.
    Tatar O, Shinoda K, Kaiserling E, Pertile G, Eckardt C, Mohr A, Yoeruek E, Szurman P, Bartz-Schmidt KU, Grisanti S.
    Arch Ophthalmol; 2008 Feb; 126(2):193-9. PubMed ID: 18268209
    [Abstract] [Full Text] [Related]

  • 4. Effect of bevacizumab on inflammation and proliferation in human choroidal neovascularization.
    Tatar O, Yoeruek E, Szurman P, Bartz-Schmidt KU, Tübingen Bevacizumab Study Group, Adam A, Shinoda K, Eckardt C, Boeyden V, Claes C, Pertile G, Scharioth GB, Grisanti S.
    Arch Ophthalmol; 2008 Jun; 126(6):782-90. PubMed ID: 18541840
    [Abstract] [Full Text] [Related]

  • 5. Clinical evidence of intravitreal triamcinolone acetonide in the management of age-related macular degeneration.
    Becerra EM, Morescalchi F, Gandolfo F, Danzi P, Nascimbeni G, Arcidiacono B, Semeraro F.
    Curr Drug Targets; 2011 Feb; 12(2):149-72. PubMed ID: 20887246
    [Abstract] [Full Text] [Related]

  • 6. Expression of VEGF and PEDF in choroidal neovascular membranes following verteporfin photodynamic therapy.
    Tatar O, Adam A, Shinoda K, Stalmans P, Eckardt C, Lüke M, Bartz-Schmidt KU, Grisanti S.
    Am J Ophthalmol; 2006 Jul; 142(1):95-104. PubMed ID: 16815256
    [Abstract] [Full Text] [Related]

  • 7. Consequences of verteporfin photodynamic therapy on choroidal neovascular membranes.
    Tatar O, Kaiserling E, Adam A, Gelisken F, Shinoda K, Völker M, Lafaut BA, Bartz-Schmidt KU, Grisanti S.
    Arch Ophthalmol; 2006 Jun; 124(6):815-23. PubMed ID: 16769835
    [Abstract] [Full Text] [Related]

  • 8. Effect of verteporfin photodynamic therapy on endostatin and angiogenesis in human choroidal neovascular membranes.
    Tatar O, Shinoda K, Adam A, Eckert T, Eckardt C, Lucke K, Deuter C, Bartz-Schmidt KU, Grisanti S.
    Br J Ophthalmol; 2007 Feb; 91(2):166-73. PubMed ID: 16987895
    [Abstract] [Full Text] [Related]

  • 9. Implications of bevacizumab on vascular endothelial growth factor and endostatin in human choroidal neovascularisation.
    Tatar O, Shinoda K, Kaiserling E, Claes C, Eckardt C, Eckert T, Pertile G, Boeyden V, Scharioth GB, Yoeruek E, Szurman P, Bartz-Schmidt KU, Tuebingen Bevacizumab Study Group, Grisanti S.
    Br J Ophthalmol; 2009 Feb; 93(2):159-65. PubMed ID: 18838410
    [Abstract] [Full Text] [Related]

  • 10. Photodynamic therapy with intravitreal application of triamcinolone acetonide in age-related macular degeneration: functional results in 54 patients.
    Frimpong-Boateng A, Bunse A, Rüfer F, Roider J.
    Acta Ophthalmol; 2009 Mar; 87(2):183-7. PubMed ID: 18547278
    [Abstract] [Full Text] [Related]

  • 11. Effect of photodynamic therapy alone or combined with posterior subtenon triamcinolone acetonide or intravitreal bevacizumab on choroidal hypofluorescence by indocyanine green angiography.
    Hatta Y, Ishikawa K, Nishihara H, Ozawa S, Ito Y, Terasaki H.
    Retina; 2010 Mar; 30(3):495-502. PubMed ID: 19996828
    [Abstract] [Full Text] [Related]

  • 12. Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization.
    Grossniklaus HE, Ling JX, Wallace TM, Dithmar S, Lawson DH, Cohen C, Elner VM, Elner SG, Sternberg P.
    Mol Vis; 2002 Apr 21; 8():119-26. PubMed ID: 11979237
    [Abstract] [Full Text] [Related]

  • 13. Vitreous mediators after intravitreal bevacizumab or triamcinolone acetonide in eyes with proliferative diabetic retinopathy.
    Arimura N, Otsuka H, Yamakiri K, Sonoda Y, Nakao S, Noda Y, Hashiguchi T, Maruyama I, Sakamoto T.
    Ophthalmology; 2009 May 21; 116(5):921-6. PubMed ID: 19410951
    [Abstract] [Full Text] [Related]

  • 14. Combination of photodynamic therapy and intraocular triamcinolone for exudative age-related macular degeneration and long-term chorioretinal macular atrophy.
    Piermarocchi S, Sartore M, Lo Giudice G, Maritan V, Midena E, Segato T.
    Arch Ophthalmol; 2008 Oct 21; 126(10):1367-74. PubMed ID: 18852414
    [Abstract] [Full Text] [Related]

  • 15. Three-year visual outcome of photodynamic therapy plus intravitreal bevacizumab with or without subtenon triamcinolone acetonide injections for polypoidal choroidal vasculopathy.
    Sakai T, Ohkuma Y, Kohno H, Hayashi T, Watanabe A, Tsuneoka H.
    Br J Ophthalmol; 2014 Dec 21; 98(12):1642-8. PubMed ID: 25053762
    [Abstract] [Full Text] [Related]

  • 16. Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of choroidal neovascularisation secondary to pathological myopia: a pilot study.
    Chan WM, Lai TY, Wong AL, Liu DT, Lam DS.
    Br J Ophthalmol; 2007 Feb 21; 91(2):174-9. PubMed ID: 16987898
    [Abstract] [Full Text] [Related]

  • 17. Photodynamic therapy combined with posterior subtenon triamcinolone acetonide injection in the treatment of choroidal neovascularization.
    Lee YA, Ho TC, Chen MS, Yang CH, Yang CM.
    Eye (Lond); 2009 Mar 21; 23(3):645-51. PubMed ID: 18292791
    [Abstract] [Full Text] [Related]

  • 18. Expression of leukocyte adhesion molecules in human subfoveal choroidal neovascular membranes treated with and without photodynamic therapy.
    Yeh DC, Bula DV, Miller JW, Gragoudas ES, Arroyo JG.
    Invest Ophthalmol Vis Sci; 2004 Jul 21; 45(7):2368-73. PubMed ID: 15223819
    [Abstract] [Full Text] [Related]

  • 19. Protective effect of intravitreal bevacizumab and sub-tenon triamcinolone acetonide against occlusion of choriocapillaris induced by photodynamic therapy.
    Mukai R, Kishi S, Sato T, Watanabe G, Matsumoto H.
    Ophthalmologica; 2010 Jul 21; 224(5):267-73. PubMed ID: 20185940
    [Abstract] [Full Text] [Related]

  • 20. Expression of vasohibin, an antiangiogenic factor, in human choroidal neovascular membranes.
    Wakusawa R, Abe T, Sato H, Yoshida M, Kunikata H, Sato Y, Nishida K.
    Am J Ophthalmol; 2008 Aug 21; 146(2):235-243. PubMed ID: 18486097
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.